Reata Pharmaceuticals, Inc. to Report Third Quarter 2019 Financial Results and to Provide an Update on Development Programs o...
November 05 2019 - 6:45AM
Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage
biopharmaceutical company, today announced that it will report
financial results and provide an update on recent progress on its
development programs on November 12, 2019, before the market opens.
Reata’s management with host a conference call
at at 8:00 a.m. ET. The conference call will be accessible by
dialing (844) 348-3946 (toll-free domestic) or (213) 358-0892
(international) using the access code: 4159656. The webcast
link is https://edge.media-server.com/mmc/p/ofwujzj9.
Third quarter financial results to be discussed
during the call will be included in an earnings press release that
will be available on the company’s website shortly before the call
at http://reatapharma.com/investors/ and will be available for 12
months after the call. The audio recording and webcast will
be accessible for at least 90 days after the event at
http://reatapharma.com/investors/.
About Reata Pharmaceuticals,
Inc.
Reata is a clinical-stage biopharmaceutical
company that develops novel therapeutics for patients with serious
or life-threatening diseases by targeting molecular pathways
involved in the regulation of cellular metabolism and
inflammation. Reata’s two most advanced clinical candidates,
bardoxolone methyl (bardoxolone) and omaveloxolone, target the
important transcription factor Nrf2 that promotes restoration of
mitochondrial function, reduction of oxidative stress, and
inhibition of pro-inflammatory signaling. Bardoxolone
and omaveloxolone are investigational drugs, and their safety and
efficacy have not been established by any agency.
Contact:Reata Pharmaceuticals, Inc.(972)
865-2219http://reatapharma.com
Investors:Vinny JindalVice President,
Strategy(469)
374-8721ir@reatapharma.comhttp://reatapharma.com/contact-us/
Media:Matt Middleman, M.D.LifeSci Public
Relations(646)
627-8384matt.middleman@lifescipublicrelations.com
Reata Pharmaceuticals (NASDAQ:RETA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Reata Pharmaceuticals (NASDAQ:RETA)
Historical Stock Chart
From Sep 2023 to Sep 2024